
Delcath Systems DCTH
$ 11.48
0.0%
Quarterly report 2026-Q1
added 05-07-2026
Delcath Systems Interest Expense 2011-2026 | DCTH
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Delcath Systems
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 1988 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -70 K | -30 K | -59 K | 30 K | 68 K | 154 K | 2 K | 51 K | 21.7 M | 14.3 M | 67 K | -24 K | -81 K | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 21.7 M | -81 K | 2.78 M |
Quarterly Interest Expense Delcath Systems
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -58 K | -33 K | -34 K | 4 K | - | 35 K | 10 K | -22 K | - | -5 K | 6 K | 13 K | - | 26 K | -8 K | -15 K | - | -9 K | 61 K | 21 K | - | 33 K | - | - | - | 4 K | 1 K | 2 K | - | -10 K | -5 K | -5 K | - | 5.04 M | 6.92 M | 8 K | - | 4.96 M | 1.61 M | -28 K | - | -11 K | -28 K | 11 K | - | -23 K | 7 K | -15 K | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6.92 M | -58 K | 528 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Apyx Medical Corporation
APYX
|
-161 K | $ 3.67 | - | $ 151 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 4.13 | - | $ 155 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 17.81 | - | $ 418 M | ||
|
Alphatec Holdings
ATEC
|
45.9 M | $ 7.52 | - | $ 1.13 B | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
LENSAR
LNSR
|
636 K | $ 5.64 | - | $ 67.4 M | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 2.22 | - | $ 1.35 M | ||
|
BioSig Technologies
BSGM
|
1.6 M | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 12.82 | - | $ 363 M | ||
|
Orthofix Medical
OFIX
|
8.11 M | $ 11.65 | - | $ 461 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Profound Medical Corp.
PROF
|
146 K | $ 6.85 | - | $ 207 M | ||
|
LivaNova PLC
LIVN
|
664 K | $ 71.86 | - | $ 3.92 B | ||
|
Sintx Technologies
SINT
|
31 K | $ 2.35 | - | $ 6.52 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
Myomo
MYO
|
-668 K | $ 0.83 | - | $ 34.7 M | ||
|
Electromed
ELMD
|
78 K | $ 26.93 | - | $ 228 M | ||
|
Butterfly Network
BFLY
|
-13 K | $ 4.16 | - | $ 881 M | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Insulet Corporation
PODD
|
14.3 M | $ 154.16 | - | $ 10.8 B | ||
|
Globus Medical
GMED
|
3.41 M | $ 77.95 | - | $ 10.5 B | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 36.76 | - | $ 1.14 B | ||
|
TransMedics Group
TMDX
|
3.87 M | $ 67.84 | - | $ 2.31 B | ||
|
Inspire Medical Systems
INSP
|
-2.66 M | $ 44.26 | - | $ 1.3 B | ||
|
Integer Holdings Corporation
ITGR
|
-53.2 M | $ 88.12 | - | $ 3.06 B | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 79.96 | - | $ 46.8 B |